In human lung adenocarcinomas, increased expression of both p-eIF2α and ATF4 is mainly observed in advanced tumor subtypes with aggressive growth patterns, high risk of recurrence, and poor prognosis [22,23]. The gene discussed is ATF4; the disease is neoplasm.